Month: July 2020

Strong commercial dynamicOrder entry up +9.4% year-on-year, Book to bill ratio at 112% (Q2 at 121%)Revenue at € 5,627 million, -2.8% organically (Q2 at -4.8%)Cost actions leading to an Operating margin at € 450 million, 8.0% of revenueWorking capital timing effects leading to a Free cash flow at € -172 millionNormalized diluted EPS at € 2.93Cybersecurity and Decarbonization acquisitions announced todayAll 2020 objectives confirmedParis, July 27, 2020 – Atos, a global leader in digital transformation, today announced its financial results for the first half of 2020.Elie Girard, CEO, said: “During the first half of 2020, in the very specific context of the pandemic, we prioritized the health and safety of our people, while ensuring business continuity to our customers by delivering critical services supported by our resilient business...

 Une forte dynamique commercialeDes prises de commandes en hausse de +9.4%, un ratio prise de commandes sur chiffre d’affaires de 112% (121% au deuxième trimestre)Un chiffre d’affaires à 5 627 millions d’euros, -2,8% à périmètre et taux de change constants (-4,8% au deuxième trimestre)Des actions fortes sur les coûts conduisant à une marge opérationnelle de 450 millions d’euros, soit 8,0% du chiffre d’affairesDes décalages temporaires sur le besoin en fonds de roulement portant le flux de trésorerie disponible à -172 millions d’eurosUn Bénéfice Normalisé par Action Dilué à 2,93 €Acquisitions en Cybersécurité et en Décarbonation annoncées aujourd’huiTous les objectifs 2020 sont confirmésParis, le 27 juillet 2020 Atos, leader international de la transformation digitale, annonce aujourd’hui ses résultats financiers pour le premier semestre...

Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®Second API Supplier for BARHEMSYS® Receives FDA ApprovalThis announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.Cambridge, UK and Indianapolis, US – 27 July 2020: Acacia Pharma Group plc (“Acacia Pharma” or the “Company”) (EURONEXT: ACPH), announces that the US Food and Drug Administration (FDA) has approved of a second supplier for the active pharmaceutical ingredient (API) for BARHEMSYS® (amisulpride injection). BARHEMSYS was approved for the treatment and prevention of PONV in the US in February 2020.The approval significantly increases the Company’s commercial product stock levels ahead of the US launch of BARHEMSYS. The Company anticipates the approval of a second supplier will support its ability to...

Paris, July 27, 2020 – Atos, a global leader in digital transformation, today announces that it has entered into exclusive negotiations with shareholders from digital.security with a view to acquiring the company. digital.security, a subsidiary of Econocom group, is a leading independent player in cybersecurity in France and BeLux. This strategic move will confirm Atos’ leading position in cybersecurity services in France with 500 dedicated experts and will also strengthen its number 1 position in Europe.Atos will benefit from digital.security’s 250 cybersecurity consultants and specific IoT knowledge, offering significant synergy with Atos’ activities and customers – while digital.security will benefit from Atos’ extensive expertise and leading rankings in Managed Security Services.Created in 2015 with the support of Econocom and led...

PRESS RELEASE 27 JULY 2020Italeaf: the subsidiary algoWatt developed innovative artificial intelligence solutions for environmental managementDeveloped with the contribution of the internal R&D department two systems based on artificial intelligence for the optimization of production flows and predictive modelling of landfillsThe two automated systems were implemented in a biodigester treatment plant in Umbria and in the Monte Scarpino (GE) landfillItaleaf SpA, holding company and first Italian company builder active in the cleantech and smart innovation sectors, listed on the NASDAQ First North Growth Market of the Stockholm Stock Exchange, announces that the subsidiary algoWatt, GreenTech Solutions company listed on Borsa Italiana’s electronic stock exchange (MTA), has completed the in-house design and development of innovative...

COMUNICATO STAMPA 27 LUGLIO 2020Italeaf: la subsidiary algoWatt sviluppa innovative soluzioni di artificial intelligence al servizio della gestione ambientale            ·Sviluppati con il contributo del dipartimento interno di R&S due sistemi basati sull’artificial intelligence per l’ottimizzazione dei flussi di produzione e la modellazione predittiva delle discariche            ·I due sistemi automatizzati sono stati implementati in un impianto di trattamento FORSU in Umbria e nella discarica di Monte Scarpino (GE)Italeaf SpA, holding di partecipazione e primo company builder italiano attivo nei settori cleantech e smart innovation, quotata al NASDAQ First North Growth Market della Borsa di Stoccolma, comunica che la subsidiary algoWatt, GreenTech Solutions Company quotata sul mercato telematico azionario (MTA) di Borsa Italiana,...

TORONTO, July 27, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, today announced the resignation of Dr. Hugh Scully from its Board of Directors, effective immediately.  “Dr. Scully was recently reappointed to the Board of Directors, but a personal matter has arisen which has led him to submit his resignation. Dr. Scully has been on the Board of Starseed since its inception in 2013 and was an important contributor to its success,” said George Scorsis, Executive Chairman of WeedMD. “On behalf of the Board of Directors and management team, we want to thank Dr. Scully for his positive contribution while at Starseed and WeedMD, and wish him the best in his future endeavors.”Check here for upcoming corporate events...

– TC-210 TRuC-T cell monotherapy induced tumor regression in first five patients– Two RECIST unconfirmed partial responses and two patients with stable disease through six months      – Manageable toxicity profile, with only one patient exhibiting TC-210-related non-hematologic Grade >2 toxicity      – Translational data demonstrated T cell expansion and cytokine production– TCR2 to host conference call today starting at 8:00am E.T. with live webcast available onlineCAMBRIDGE, Mass., July 26, 2020 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced positive interim data from the first five patients treated in the Phase 1 portion of the TC-210 Phase 1/2 clinical trial...

Sabodala-MassawaFirst 5-year average annual production of 384,000 ounces at all-in sustaining costs of $671/oz(1)(2)First 5-year average net cash flow of $215 million per year at $1,600/oz gold*First 5-year total net cash flow of $1.1 billion at $1,600/oz gold*Proven and probable reserves increase 120% to 4.8 million ounces at $1,250/oz goldMining activities at Massawa now underway$10-million exploration and drill program is ongoing at MassawaCompany-WideProven and probable reserves increase by 70% to 6.4 million ounces of goldAverage annual gold production expected to increase by 40% to ~500,000 ounces(3)(All amounts are in U.S. dollars unless otherwise stated)TORONTO, July 26, 2020 (GLOBE NEWSWIRE) — Teranga Gold Corporation (“Teranga” or the “Company”) (TSX: TGZ) (OTCQX: TGCDF) is pleased to announce the...

Historically, the low-interest rate in this decade has led the Canadian investors to enhance the venture in the world of the private MIC or Canada mortgage investment corporation. The structure promises a steady return to have good yield when compared to the traditional fixed-income investment these days. When you need to enjoy the full benefits of the body, you need to know some significant aspects of it. MICs are the pools of capital that invest in the private mortgage in the country. It is the way through which the investor will gain direct exposure to the mortgage market. These account for the bulk of private mortgage issuances, and it is regulated by OFSI. It is not only responsible for the income tax, but it is also for the corporate structure that all of them distribute all the earnings to investments. This mortgage investment corporation...